Neurology biotech Voyager Therapeutics has laid off 30 employees, a spokesperson for the Massachusetts-based company ...

Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s ...

Voyager 1 and 2 have traveled billions of miles over nearly half a century. NASA intends the Voyager program to continue its historic exploration for at least another few years. But after nearly half ...

- Additional new data demonstrate VY-TAU01, Voyager’s lead antibody targeting pathological tau, was well-tolerated and demonstrated favorable pharmacokinetics in non-human primates (NHPs) - - Data to ...

The Voyager program is an ongoing American scientific program that employs two robotic interstellar probes, Voyager 1 and Voyager 2. They were launched in 1977 to take advantage of a favorable ...

- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s ...

NPR's Lulu Garcia-Navarro talks to Ed Stone, a chief scientist at NASA, about the Voyager program as it approaches its 40th anniversary. He's 81 years old and has spent half his life on the project.

- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial ...

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...

The U.S. Small Business Administration recently authorized Eden Prairie-based Voyager Bank to be one of the first nine banks nationwide to act as a Loan Pool Originator of 504 1st REM loans. The SBA ...